Allarity Therapeutics ALLR
NASDAQ ALLR
$1.05 +0.08 (+8.25%)
At close: Sep 30, 2026 · 4:00 PM EDT

Allarity Therapeutics (ALLR) Revenue (2026)

Updated

Allarity Therapeutics (ALLR) reported Revenue of $25,000 for Q1 2026.

Analysis

Allarity Therapeutics (ALLR) Revenue (2026) Analysis & Trends

For FY2025, Allarity Therapeutics posted Revenue of $320,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 25.31 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 16.99 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 15.38 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 3.33 Bn
10 Allarity Therapeutics 1.56 Mn 1.56 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 25,000.00
API Access

Allarity Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ALLR&period=max&api_key=YOUR_API_KEY